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Robust rapid‑setting antibacterial 
liquid bandages
carlos A. p. Bastos1,3*, William D. Thom1,3, Beth Reilly1, Iris L. Batalha2, 
Maedee L. Burge Rogers1, Ian S. McCrone1, Nuno Faria1,4 & Jonathan J. Powell1,4*
Bandaging is a steadfast but time-consuming component of wound care with limited technical 
advancements to date. Bandages must be changed and infection risk managed. Rapid-set liquid 
bandages are efficient alternatives but lack durability or inherent infection control. We show here 
that antibacterial zinc (Zn) and copper (Cu) species greatly enhance the barrier properties of the 
natural, waterproof, bio-adhesive polymer, shellac. The material demonstrated marked antibacterial 
contact properties and, in ex-vivo studies, effectively locked-in pre-applied therapeutics. When 
challenged in vivo with the polybacterial bovine wound infection ‘digital dermatitis’, Zn/Cu-shellac 
adhered rapidly and robustly over pre-applied antibiotic. The bandage self-degraded, appropriately, 
over 7 days despite extreme conditions (faecal slurry). Treatment was well-tolerated and clinical 
improvement was observed in animal mobility. This new class of bandage has promise for challenging 
topical situations in humans and other animals, especially away from controlled, sterile clinical 
settings where wounds urgently require protection from environmental and bacterial contamination.
Bandaging is an enduring approach to the medical and surgical management of wounds, with a myriad of ben-
efits; including, provision of structural support, prevention of ingress of dirt and infectious microbes from the 
environment, and the securing of dressings and topical therapeutics (e.g. antibiotics) at afflicted  sites1–3. The 
principal drawbacks of conventional bandages are (1) the inconvenient and/or labour-intensive application that 
is required (2) the requirement for regular changing, to avoid them becoming niduses for infection and (3) the 
requirement for antimicrobial under-dressings.
Liquid bandage formulations are potentially well placed to redress these limitations, being facile to apply and 
intrinsically amenable to modification for added functionality or fine-tuning. Ideally, liquid bandage formula-
tions should produce robust protective barriers, comprise safe, biodegradable components, and may even offer 
additional functionality to promote wound  healing4. One approach adopted by the more advanced conventional 
(i.e. solid) bandages is to impart them with antimicrobial  properties2,5 such that they remain sterile during use 
and are not harbingers for biofilm formation. Metal ions are attractive for this purpose, being antibiotic-sparing 
and having broad-spectrum  activity6. In particular, silver has seen wide-spread topical  usage5,7–9 and, although 
potent as a released ion, it is actually inferior to copper at contact  killing10,11. Silver, if released into the wound, 
is also potentially problematic to eukaryotic  cells12,13. In contrast, copper and zinc are physiologically essential 
trace-minerals and, if leached into the wound significantly, their antibacterial properties could be harnessed by 
the innate immune system as part of our natural repertoire for fighting  infections14,15.
In this work, we employed copper, zinc, and shellac—a natural, safe resin used in confectionary and 
 cosmetics16—to develop robust, rapid-setting, liquid bandages with inherent antibacterial repellent (contact 
killing) properties. For proof-of-principle in vivo application and tolerability we considered a worst-case-scenario 
challenge, namely digital dermatitis, a chronic, contagious, polybacterial infection that afflicts the feet of dairy 
cows with painful lesions. It impairs mobility, milk production and quality of  life17,18. Continuous mechanical 
stress and exposure to bacterial-rich slurry make topical treatment of digital dermatitis extremely  challenging3. 
To narrow down the various formulations for in vivo testing their in vitro efficacy was first determined against 
Escherichia coli. In digital dermatitis the causative organisms are typically anaerobes and very difficult to culture. 
E. coli, in contrast, is a standard laboratory model bacterium that is a facultative anaerobe. However, since copper 
ions and copper surfaces have broad spectrum antibacterial  properties19,20 we considered that the ‘E. coli test’ 
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would be a suitable triage system to answer the question of whether the material’s metal ions were available for 
bacterial contact killing or not.
Results
Shellac is highly soluble in ethanol and its solutions readily yield solid adhesive layers upon evaporation: i.e. after 
being applied to  surfaces16. In the initial phase of development, we therefore assessed, visually, how well copper- 
and zinc-based materials mixed with shellac/ethanol solutions. Both simple salts (i.e. copper or zinc chloride) 
and acetate complexes integrated well into shellac/ethanol solutions. Moreover, in the semi-quantitative retention 
assay, the presence of these metal species appeared, generally, to enhance shellac barrier adhesion on a semi-rigid 
fabric surface exposed to an aqueous environment (Supplementary Figure S1). Before assessing this formally, 
we sought to hone in on a lead material based upon antibacterial effectiveness and stability of the antibacte-
rial metals in the barrier. As such, a series of nine rapid-setting liquid materials were produced by varying the 
metal:shellac:ethanol ratios, the nature of the metal compound, and/or the addition of plasticizers, as described 
in Materials and Methods and summarised in Table 1. In the contact killing assay against E. coli, four materials 
resulted in undetectable bacterial counts at 24 h (Fig. 1a): these were termed CAZ, ZAF, CAF and CAZα (see 
Table 1 for material descriptions). Each of these released some metal ions into the bacterial medium over the 
same time period but, of the four, release was lowest for CAZ, which contained 100 mMol/kg copper acetate and 
100 mMol/kg zinc chloride (Fig. 1b). CAZ, therefore, was the preferred option for downstream application to 
digital dermatitis lesions, due to its ability to contact kill bacteria without substantial leaching of its metal ions 
into an aqueous environment (Fig. 1c). However, prior to in vivo testing we confirmed that CAZ should be ‘fit 
for purpose’ through further in vitro tests. Structurally, CAZ formed thick and robust barriers (Fig. 1d). Imaging 
via helium ion microscopy revealed smooth surfaces of even contrast (Fig. 1e), indicating a homogenous surface 
 layer21. However, similar cross-sectional imaging of CAZ films revealed distinct striations (Fig. 1f) consistent 
with either auto-stratification22,23 or significant variation in local  topography24.
Importantly, in assays mimicking exposure to alkaline slurry (pH 8.5), as encountered by digital dermatitis 
lesion-bearing and infected hooves on dairy farms, CAZ barriers were highly resistant to degradation over 24 h 
(Fig. 2a) regardless of exposure volume (i.e. barrier to slurry ratio). This contrasts with barriers produced by an 
equivalent metal-free shellac (40% w/w) formulation, which showed only some resistance under the mildest con-
ditions (assay ratio of 1:5) but were fully degraded by greater volumes of slurry-ratios of 1:10 and higher (Fig. 2a). 
Subsequent ex vivo assays assessed the effectiveness of CAZ barriers at ‘locking in’ pre-applied therapeutics. 
Typically, digital dermatitis treatment entails repeated applications of antibiotic spray to an affected area until a 
healing lesion is  achieved25. Sprays comprise an active antimicrobial (e.g. oxytetracycline or chlortetracycline) 
and added colorants to enable visualisation of the treatment. Here, leaching of blue dye from a chlortetracycline-
based spray was used to demonstrate the ‘lock-in’ effectiveness of CAZ, versus no barrier (antibiotic spray alone; 
current gold standard), on bovine cadaver legs. Spray was applied between the interdigital cleft and dew claws of 
each leg. After a brief drying period (60 s), legs were either directly immersed in 1 L of simulated slurry for an 
hour (non-barrier group), or bandaged with CAZ and, after a 2 min setting period, immersed in 1 L simulated 
slurry (barrier group). Notably, almost 90% of the antibiotic, quantified via the dye-proxy, was retained with the 
CAZ barrier, in contrast with less than 15% for the non-barrier group (Fig. 2b).
Finally, in vivo, we assessed tolerability and robustness of the CAZ barrier in 7 cows with compromised mobil-
ity (scores of one or greater—zero denoting healthy  movement26) and active digital dermatitis lesions. Lesions 
were treated with chlortetracycline spray as per standard care. After 30 s, 5–10 g of CAZ barrier were applied 
on top of the spray. This was allowed to dry for 2 min, photographed and cows were then returned to the herd. 
Where possible, at days 2, 4 and 7, the lesions were gently washed and re-photographed (Fig. 3a–h). Mobility 
scores were recorded again at day 7. Images were graded by an independent observer as (1) effective barrier 
coverage, (2) residual barrier or (3) no visible barrier. In all cases CAZ adhered well upon application (Fig. 3i). By 
day two, 4 out of the 6 lesions that could be reviewed still had effective barrier coverage whereas, by day 7, only 
1 lesion showed clear evidence of residual barrier (Fig. 3i). Throughout, there was no evidence of local adverse 
responses to the CAZ barrier. In fact, with the single treatment, lesions healed and for all animals at day 7, lame-
ness was ameliorated to a significant extent (p = 0.03 v day 1) with mobility scores normalised to 0 or 1 (Fig. 3j).
Table 1.  Identities and components of prepared liquid bandage formulations. All materials contain shellac at 
40% (weight by weight) in ethanol solvent.
Material name Copper Zinc Additives
MF – – –
CC CuCl2 – –
CA CuAc2 – –
CAF CuAc2 – FeCl3
ZAF – ZnAc2 FeCl3
CAZ CuAc2 ZnCl2 –
CAZα CuAc2 ZnCl2 ZnO; triethyl citrate
CAZp CuAc2 ZnCl2 Polyethylene glycol (~ 400 Da); glycerol
CCβ CuCl2 ZnCl2 Benzoic acid
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Discussion
Whilst rapid-set liquids, for beneficial application to lesions, are not new, the existing products (e.g. polyacrylate 
aerosol sprays) form weak barriers that are neither biodegradable nor antimicrobial. Moreover, they cannot be 
used for farm animals as they are not acceptable components of the food chain. Overall, there is an unmet need 
for robust, sterile liquid bandages with broad applicability across humans and other animals including, for the 
latter, those contributing to the human food chain.
Here, we demonstrate a novel class of antibacterial, rapid-setting, liquid bandage that utilises the natural resin, 
shellac, at high film former content (40% w/w) to produce durable in situ bandages when applied to synthetic 
surfaces, cadaver limbs and bovine wounds. Incorporating antibacterial metals (chiefly  Cu2+ and  Zn2+) in the 
formulation conveyed contact-killing properties which is also a first-in-class functionality for liquid bandages. 
This property is aimed at limiting the potential for continuous bacterial colonisation of the dressing, or bacterial 
Figure 1.  In vitro characterization of liquid bandages. (a) E. coli concentration (log CFU/mL) after 24 h 
incubation on a range of barrier surfaces in a dynamic contact killing assay. The dotted line represents the assay’s 
limit of detection (LOD) of 1.7 log CFU/mL. (b) Copper and zinc release from barriers into the culture medium 
(lysogeny broth) during the contact killing assay as determined by inductively coupled plasma optical emission 
spectroscopy. (c) A combined plot of contact killing ability (log CFU/mL) and total metal release (the sum of 
copper and zinc), with colour coded outcomes. Ideal material characteristics (antibacterial contact killing with 
minimal metal release) is indicated by the green region and was best achieved by material CAZ (star symbol). 
Control (i.e. barrier free) results are denoted by the letter ‘L’. (d) Exemplification of barrier formation upon 
application of CAZ to a polyethylene surface. Helium ion microscopy images of (e) surface (scale bar, 200 µm) 
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Figure 2.  Barrier degradation and antibiotic locking. (a) Mass losses of barriers upon exposure to increasing 
amounts of simulated slurry for dried materials without (shellac) or with (CAZ) the presence of antimicrobial 
metal ions in their formulation (n = 3). (b) Ex vivo losses of antibiotic spray (quantified by loss of its dye, Patent 
Blue V) in simulated slurry (75 mMol/kg ammonium carbonate; n = 4) in the absence or presence of the CAZ 
barrier, with statistical analysis via two-tailed Mann–Whitney U test. Error bars represent experimental standard 
deviations.
Figure 3.  In vivo proof of principle testing in farm animals with digital dermatitis. (a, b) Digital dermatitis 
lesion (c) with antibiotic applied (d) immediately followed by CAZ barrier to form a bandage on day 0. The 
subsequent images show the exact same region (e) on day 2, (f) day 4 and (g, h) day 7. (i) Barrier integrity, 
assessed by the blind scoring of (coded) images after CAZ application (Day 0) and then at days 2 and 7. Dark 
blue represents effective barrier coverage; light blue is clear residual barrier and white means no obviously visible 
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ingress into the wound, thus aiding in the maintenance of a sterile wound environment which gives best chance 
to the natural healing process. It also removes the necessity for both a dressing and a bandage, as it serves these 
purposes in one.
Metal ion addition to the formulation also benefited physical and chemical properties of the materials by 
enhancing both adhesion to application sites and barrier durability in aqueous environments. We are yet to 
elucidate the precise mechanisms for these effects. However, it is notable that shellac’s constituent aliphatic and 
alicyclic acids have pKa values in the range of 5.8–6.127 and that their deprotonation under neutral and alkaline 
conditions increase the polymer’s aqueous solubility. It is possible that in the presence of transition metals, these 
carboxylate moieties instead become co-ordinating bridges between neighbouring polymer strands, forming 
supramolecular metal organic framework (MOF)-like structures, and thereby retarding dissolution. Irrespective 
of the precise mechanism, this behaviour allowed us to tailor degradation rates via compositional fine-tuning 
(metal and shellac content) such that, in preliminary in vivo testing, our material resisted the extensive stresses 
of the bovine hoof environment for at least 2 days before self-degrading. Importantly, as described, it was also 
well tolerated, allowed wound-healing and was effective at ‘locking in’ pre-applied therapeutics. These features 
pave the way to much-needed one-shot combination therapy options for digital dermatitis given that the cur-
rent gold standard (repetitive applications of topical antibiotic) is impractically labour intensive, whilst dressing 
antibiotic with traditional bandages is time consuming and runs the risk of fouling should the bandage be left in 
place. Self-degrading bandages obviate this risk and, as such, CAZ is a ‘first in class’ for a robust liquid bandage 
in several aspects.
More generally, there are many scenarios, in humans and animals, where these new materials could find 
usage as devices to cover wounds, lesions and burns that benefit from rapid isolation from their environment 
and a de facto ‘second skin’. Surgery, trauma (including burns) and disease-associated lesions (as reported here) 
would be major target applications. In particular, the difficult-to-get-to lesions as well as those occurring ‘in the 
field’, rather than a controlled clinical setting, could especially benefit from this technology. Infected and wet 
environments deliver a further challenge that these materials rise to especially well. Even upon exposure to an 
aqueous liquid before setting, the barrier formulations immediately cure and repel the fluid.
Our main clinical goal was to really challenge these new materials and to see how they would perform when 
applied to difficult areas, with open wounds, in an infection- and water-rich environment on a host without 
conscious compliance. Bovine digital dermatitis was therefore our test bed. This is a relapsing and remitting 
disease, and our aim, here, was proof-of-principle rather than a clinical trial but it convincingly demonstrated 
that the barrier is easily applied, is robust and well tolerated, locks in a pre-applied therapeutic and allows lesions 
to heal. Whether this will turn out to be a superior method for dealing with digital dermatitis, compared to cur-
rent state-of-art management, would require a controlled trial with larger numbers but it is worth noting that 
Klawitter et al.3, cite an urgent requirement for new approaches to bandaging in this disease and we believe that 
the materials presented here have that potential.
Materials and methods
Preparation of liquid bandage formulations. All reagents were purchased from Sigma apart from 
ethanol (Fischer Scientific) and de-waxed (< 0.5%) shellac (A.F. Suter & Co; Shellac Dewaxed flakes HS702MB). 
The shellac flakes were blended to powder using a Waring Blender 8011EG.
Liquid bandages were prepared by the sequential mixing of (a) metal salts (copper, zinc and/or iron), (b) 
additives (e.g. triethyl citrate, ZnO), and (c) shellac, in ethanol solvent via roller mixer (Denley Spiramix 5, 
Thermo Scientific, UK). Soluble copper and zinc salts (acetate and chloride) were each added in quantities suf-
ficient to produce bandage formulations at 100 mMol/kg, whilst ferric chloride was added at 66 mMol/kg (CAF 
and ZAF materials). Additives were employed in a number of materials with the intent of imparting additional 
functional benefits via (1) increased metal content: 1% ZnO, 8% triethyl citrate dispersant (CAZα), (2) presence 
of an organic antimicrobial and preservative: 40 mMol/kg benzoic acid—neutralised with KOH (CCβ), or (3) 
plasticizers: 12% polyethylene glycol (~ 400 Da), 5% glycerol (CAZρ). Finally, blended shellac was added at 40% 
(by weight) to disperse solutions and agitated via roller mixer for at least 24 h until homogeneity. The components 
of each material are tabulated in Table 1.
Helium ion microscopy. Films were imaged using a Zeiss Orion NanoFab Helium Ion Microscope (Carl 
Zeiss, Cambridge, UK). The microscope was operated at an imaging voltage of 30 kV and an aperture size of 
20 µm. An Everhart–Thornley (E–T) detector was used to image the samples.
Metal release and contact killing activity against E. coli. The contact killing activity of antibacterial 
barriers was determined using an assay adapted from the international standard ASTM  E214928. Briefly, films 
were prepared by pouring 1 mL of the liquid bandage formulations in each well on a 12-well plate and allowed 
to dry overnight at room temperature. In parallel, a saturated E. coli K12 ATCC 47076 culture in Lysogeny Broth 
(LB), ca.  109 CFU/mL, was prepared and diluted 100 × in LB—final concentration of 1.5 × 107 CFU/mL. 1 mL 
of this culture was added on top of the dried shellac formulations and incubated for 24 h at 30 °C under mild 
agitation (80 rpm, New Brunswick Innova 4000 Incubator shaker). Bacteria concentration was determined using 
agar plate counting methodology, in which samples from the E. coli culture were decimally diluted in PBS and 
plated in LB agar plates for colony counting. Barriers were considered bactericidal if no bacterial colonies were 
detected in agar plate counting method (limit of detection = 1.7 log CFU/mL).
Samples from the bacterial culture exposed to each shellac formulation were also collected to determine cop-
per and zinc content. These samples were diluted in 5%  HNO3 to concentrations below 100 mg/L of the metal 
and quantified using inductively coupled plasma optical emission spectroscopy (Jobin Yvon Horiba Ultima 2C; 
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Instrument SA, Longjumeau, France), employing a concentric nebulizer and cyclonic spray chamber. Plasma 
gas flow rate was 10 mL/min and the sample flow rate was 1 mL/min. Triplicate measurements were made 
for each sample and means and standard deviations calculated from these. Assay-sample concentrations were 
determined from matrix matched standards via their emission intensities at wavelengths of 324.754 nm (Cu) 
and 213.856 (Zn)29.
Barrier degradation. 22.5 g of material CAZ or 40% w/w shellac in ethanol were transferred to the bottom 
of 15- or 50-mL falcon tubes, and then spun for 1 min at 1500 rpm (Sorvall Legend RT 75006445 rotor) to ensure 
all material was at the bottom. The tubes were then uncapped and the formulations dried for 30 min. Next, 
simulated slurry (SS; 75 mMol/kg ammonium carbonate, pH 9.0 ± 0.230,31 was added to obtain formulation:SS 
ratios (w/w) of 1/5 (12.5 ± 0.1 g), 1/10 (25.0 ± 0.1 g), 1/15 (37.5 ± 0.1 g) and 1/20 (50.0 ± 0.1 g). The tubes were 
then rolled for 24 h at 50 rpm (Denley Spiramix 5, Thermo Scientific, UK) at room temperature, after which they 
were spun for 5 min at 3500 rpm (Sorvall Legend RT 75006445 rotor). The supernatant was disposed of and the 
remaining formulation was dried at 45 °C till constant weight.
Relative mass losses were determined against CAZ or 40% w/w shellac (2.5 g) solutions that were also dried 
to constant weight in identical tubes but not exposed to SS.
Antibiotic lock-in. Bovine cadaver limbs were employed in ex  vivo antibiotic lock-in experiments. An 
antibiotic spray formulation used for treating digital dermatitis (Animedazon Spray, containing Patent Blue 
V dye and chlortetracycline active) was applied to limbs by spraying, for 2 s, a region commonly afflicted with 
lesions (the area between the dew claws and the interdigital cleft). Spray-can masses were recorded before and 
after applications to control for the amount of antibiotic applied. Upon spraying, the antibiotic formulation 
was allowed to dry for 60 s and then limbs were either: (a) Control Group (n = 4): directly immersed in 1 L of 
simulated slurry (SS; 75 mMol/kg ammonium carbonate) or (b) Barrier Group (n = 4): treated with a barrier 
formulation (15 ± 5 g of CAZ) applied to cover the antibiotic spray-site, allowed to dry for a further 120 s and 
then immersed in 1 L of SS. After 1 h of immersion, 10 mL aliquots of SS were taken for each limb and the assay 
stopped. Samples were analysed for absorbance to determine the proportion of antibiotic formulation lost to the 
simulated slurry fluid; the strong and characteristic spectrochemical profile of Patent Blue V (λ  maxH2O = 639 
 nm32) made absorbance measurements a convenient proxy for antibiotic losses. Absorbance standards were 
prepared by serial dilution of weighed masses of antibiotic spray in the simulated slurry solution. Subsequently, 
sextuplicate aliquots (200 μL each) from each standard and assay sample were plated (Corning Co-star 96 well) 
and measured for absorbance between 350 and 850 nm. Raw spectra had noisy and variable baselines (due to 
organic contaminants on the limbs) and required processing in MATLAB (Savitsky Golay filtering followed by a 
baseline subtraction with 2nd order polynomials) to obtain reliable absorbance maxima. Finally, linear standard 
curves (concentration vs absorbance at 639 nm) were used to generate loss data for assay samples. The datasets 
comprised limited observations so, to avoid making assumptions regarding their distributions, statistical analy-
ses were performed using a non-parametric method—namely two-tailed Mann–Whitney U tests. A value of 
P < 0.05 was considered statistically significant. All statistical analyses were performed using Prism 6 (GraphPad 
Prism Software).
In vivo farm study. Eight dairy cows suffering from digital dermatitis and with impaired mobility were 
randomly selected and isolated for treatment at the Cambridge University Farm. All work was carried out under 
ethics approval from the Ethics & Welfare Committee from Department of Veterinary Medicine at the Univer-
sity of Cambridge (CR302—‘Digital dermatitis treatment using liquid barrier and copper/zinc actives in cattle’) 
and adhering to AAALAC  standards33. Briefly, for each animal, limbs were immobilised using a standard foot 
trimming crush and water-hosed to remove slurry and other detritus. Animedazon Spray, containing 2.45% w/w 
chlortetracycline, was applied and allowed to dry for a few seconds as per standard veterinary care. Subsequently, 
5–10 g of CAZ was applied – such that lesions were fully covered. After one minute, cows were released and 
allowed back into the yard. Photographs were taken during this process and during the follow up at days 2, and 
7, and subsequently used for single blind assessment of barrier integrity on a three point scale of: (A) effective 
barrier coverage, (B) clear residual barrier or (C) no obviously visible barrier. In addition, mobility scores for the 
animals were obtained from veterinarians at day 0 (before application) and day 7. Animal mobility was assessed 
by veterinarians using a standard scoring  system34 described in Table 2, in which scores varied from 0 (good 
mobility) to 3 (severely impaired mobility). Mobility score data (day 0 vs day 7) was discrete and comprised 
Table 2.  Description of the mobility scoring system used in this  study34.
Score Mobility category Description
0 Good mobility Walks with even weight bearing and rhythm on all four feet, with a flat back. Long, fluid strides possible
1 Imperfect mobility Steps uneven (rhythm or weight bearing) or strides shortened; affected limb or limbs not immedi-ately identifiable
2 Impaired mobility Uneven weight bearing on a limb that is immediately identifiable and or/obviously shortened strides (usually with an arch to the centre of the back)
3 Severely impaired mobility Unable to walk as fast as a brisk human pace (cannot keep up with the healthy herd) and signs of score 2
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limited observations so could not be assumed to follow a normal distribution, thus statistical analysis was per-
formed using Wilcoxon matched-pairs signed-rank test. Since intervention (including conventional antibiotic 
treatment) would not result in clinical worsening, single-tail testing was employed to maximise power from the 
small sample size. A value of P < 0.05 was considered statistically significant. As previously, statistical analyses 
were performed using Prism 6 (GraphPad Prism Software).
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